These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8218095

  • 1. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
    Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W.
    Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
    [Abstract] [Full Text] [Related]

  • 2. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
    Saku K, Zhang B, Liu R, Shirai K, Arakawa K.
    Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G, Taddei-Peters WC, Költringer P, Petek W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH.
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [Abstract] [Full Text] [Related]

  • 4. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
    Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J.
    Circulation; 1999 Sep 14; 100(11):1154-60. PubMed ID: 10484534
    [Abstract] [Full Text] [Related]

  • 5. [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].
    Ezhov MV, Afanas'eva OI, Benevolenskaia GF, Savchenko AP, Balakhonova TV, Liakishev AA, Pokrovskiĭ SN.
    Ter Arkh; 2000 Sep 14; 72(1):28-32. PubMed ID: 10687202
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D.
    Nutr Metab Cardiovasc Dis; 2004 Aug 14; 14(4):193-9. PubMed ID: 15553596
    [Abstract] [Full Text] [Related]

  • 7. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L, Tiret L, Luc G, Arveiler D, Ruidavets JB, Evans A, Chapman J, Cambien F, Thillet J.
    Atherosclerosis; 1999 Jun 14; 144(2):323-33. PubMed ID: 10407493
    [Abstract] [Full Text] [Related]

  • 8. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
    Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E.
    JAMA; 1997 Jun 04; 277(21):1689-95. PubMed ID: 9169895
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
    Kronenberg F, Kathrein H, König P, Neyer U, Sturm W, Lhotta K, Gröchenig E, Utermann G, Dieplinger H.
    Arterioscler Thromb; 1994 Sep 04; 14(9):1405-11. PubMed ID: 8068600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R, Lussier-Cacan S, Roy M, Minnich A, Lingenhel A, Kronenberg F, Davignon J.
    Arterioscler Thromb Vasc Biol; 1996 Jan 04; 16(1):129-36. PubMed ID: 8548413
    [Abstract] [Full Text] [Related]

  • 13. [Study of lipoprotein (a) phenotypes in Ivorian subject].
    Tiahou G, Aveynier E, Djessou P, Sess D, Cristol JP.
    Bull Soc Pathol Exot; 2005 Jun 04; 98(2):99-103. PubMed ID: 16050374
    [Abstract] [Full Text] [Related]

  • 14. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH, Fortmann SP, Marcovina SM.
    Arterioscler Thromb Vasc Biol; 1997 Feb 04; 17(2):239-45. PubMed ID: 9081676
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E.
    Kidney Int; 1999 Sep 04; 56(3):1049-57. PubMed ID: 10469373
    [Abstract] [Full Text] [Related]

  • 17. Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis.
    Asanuma Y, Kawai S, Aoshima H, Kaburaki J, Mizushima Y.
    Arthritis Rheum; 1999 Mar 04; 42(3):443-7. PubMed ID: 10088766
    [Abstract] [Full Text] [Related]

  • 18. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, König P.
    J Clin Invest; 1993 Feb 04; 91(2):397-401. PubMed ID: 8432847
    [Abstract] [Full Text] [Related]

  • 19. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C, Garzaniti A, Buscaglia P, Bonetti G, Falcone C, Fratino P, Finardi G, Geroldi D.
    J Am Coll Cardiol; 1999 Jan 04; 33(1):157-63. PubMed ID: 9935023
    [Abstract] [Full Text] [Related]

  • 20. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
    Kronenberg F, Trenkwalder E, Sturm W, Kathrein H, König P, Neyer U, Gröchenig E, Utermann G, Dieplinger H.
    Clin Genet; 1997 Nov 04; 52(5):377-86. PubMed ID: 9520130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.